IU researchers develop a breakthrough new blood test for schizophrenia

A team of researchers led by Indiana University School of Medicine faculty have developed a breakthrough new blood test for schizophrenia, a psychiatric disorder that includes hallucinations and delusions.

Can CBT help type 2 diabetes and obesity patients implement lifestyle alterations?

Researchers examine the impact of cognitive behavioral therapy (CBT) on lifestyle changes among type 2 diabetes and obesity patients.

August 9, 2023

Summit Therapeutics touts a rare triumph over Keytruda in lung cancer from a China-only Phase 3 study

Hours before America’s biggest cancer conference starts in Chicago, a small biotech may have stolen the show, touting late-stage results in a Thursday afternoon press

May 31, 2024

MASLD Predicted to Increase by 23% by Middle of the Century

BOSTON — A mathematical model predicts that the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly known as nonalcoholic fatty liver disease (NAFLD)

November 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.